Abstract
Background
Liver involvement in celiac disease (CD) is classified into autoimmune and cryptogenic. The association between CD and autoimmune liver diseases like autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis is well-established; however, the data on patients with cryptogenic cirrhosis, particularly from India, are scanty. So we did this study to find the prevalence of CD in patients with cryptogenic cirrhosis.
Methods
This was a prospective observational study, involving children of less than 18 years old attending Pediatric and Gastroenterology clinic with a diagnosis of cryptogenic cirrhosis. The patients were evaluated for CD and divided into two groups: chronic liver disease (CLD) with CD, and CLD without CD. Both the groups were followed up for 6 months. CLD with CD group was treated with gluten-free-diet (GFD) and CLD without CD group was followed up without any specific intervention except standard care of CLD.
Results
Out of 84 patients, 11 (13.1%) were diagnosed as CLD with CD. There was an improvement in hemoglobin levels, liver function tests, and Child-Pugh score after initiation of GFD in CLD with CD group.
Conclusion
The prevalence of CD in cryptogenic cirrhosis was 13.1%. Screening for CD is recommended for cryptogenic cirrhosis. Hepatic functions improve with a GFD in CD patients with cirrhosis.
Similar content being viewed by others
References
Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002;346:180–8.
Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.
Sood A, Midha V, Sood N, et al. Prevalence of celiac disease among school going children in Punjab, North India. J Gastroenterol Hepatol. 2006;21:1622–5.
Hu WT, Murray JA, Greenway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–6.
Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128 Suppl 1 :S87–9.
Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.
Maggiore G, Caprai S. Liver involvement in celiac disease. Indian J Pediatr. 2006;73:809–11.
De Franceschi L, Volta U, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.
Mounajjed T, Oxentenko A, Shmidt E, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol. 2011;136:128–37.
Philips AC, Sahney A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4:186–95.
Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother. 2000;54:368–72.
Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut. 2013;62:43–52.
Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, Eds. Harrison’s Principles of Internal Medicine. 19th ed. New York: Mc Graw Hill;2015:1989–95.
Maiwall R, Goel A, Pulimood AB, et al. Investigation into celiac disease in Indian patients with portal hypertension. Indian J Gastroenterol. 2014;33:517–23.
Lindgren S, Sjoberg K, Eriksson S. Unsuspected celiac disease in chronic cryptogenic liver disease. Scand J Gastroenterol. 1994;29:661–4.
Stevens FM, McLoughlin RM. Celiac disease is potentially treatable cause of liver failure. Eur J Gastroenterol Hepatol. 2005;17:1015–7.
Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881–8.
Korponay-Szabó IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.
Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002;87:293–6.
Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 1999;29:654–7.
Bonamico M, Pitzalis G, Culasso F, et al. Hepatic damage during celiac disease in childhood. Minerva Pediatr. 1986;38:959–63.
Volta U, De Franceschi L, Lari F, et al. Celiac disease hidden by cryptogenic hypertransaminasemia. Lancet. 1998;352:26–9.
Ozkan M, Trandafir L, Bozomitu L, et al. Liver involvement in celiac disease in children. Rev Med Chir Soc Med Nat Iasi. 2011;115:1030–4.
Singh P, Agnihotri A, Jindal G, et al. Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol. 2013;32:404–8.
Das P, Makharia GK. Gut-liver axis and disease infidelity: a subject worth exploring. Indian J Gastroenterol. 2014;33:503–6.
Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract. 2012;2012:85WE9697.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
AJ, SF, NK, PK, PG, and PCK declare that they have no conflict of interest.
Ethics statement
The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.
The study protocol was approved by the institutional review board and ethics committee.
Rights and permissions
About this article
Cite this article
Joshi, A., Falodia, S., Kumar, N. et al. Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet. Indian J Gastroenterol 37, 243–247 (2018). https://doi.org/10.1007/s12664-018-0857-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-018-0857-6